MENU
AGNPF
AS OF
Feb 3 closing price
Price
$0.04
Change
-$0.02 (-33.33%)
Capitalization
1.73M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
AGNPF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

ALGERNON HEALTH (AGNPF) Ownership - Who owns ALGERNON HEALTH?

Algernon Health Inc is a clinical-stage pharmaceutical development company focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), and stroke, including a program utilizing N,N-Dimethyltryptamine (DMT)... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
601 West Broadway
Phone
+1 604 398-4175
Employees
N/A
Web
https://www.algernonpharmaceuticals.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.73M
P/E Ratio
2.22
Total Cash
88.18K
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.09
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

AGNPF
Capitalization
1.73M
P/E Ratio
2.22
Risk (Beta)
2.09
Dividend Yield
N/A
Total Cash
88.2K
Total Cash/Share
0.00
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.74M
P/B Ratio
0.88
Cash Flow
N/A
Earnings
-0.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
30.2M
Current Ratio
0.08
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-1.73M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.07
Shares Held By Institutions
4
Shares Outstanding - Current
47.3M
Total Liabilities
3.14M
Total Volume MTD
N/A
Value
1
Gain YTD
-27.000
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AGNPF
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for AGNPF
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
601 West Broadway
Phone
+1 604 398-4175
Employees
N/A
Web
https://www.algernonpharmaceuticals.com